Author

Célia Gardet

Observed name: C. Gardet

Institution: Centre de Recherche en Cancérologie de Lyon

Observed institutions: Lyon 1 Université, Centre National de la Recherche Scientifique, Inserm, AgroParisTech, Université Paris-Saclay, Institut National de la Recherche Scientifique, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Centre Armand-Frappier Santé Biotechnologie

ORCID: 0000-0001-6559-7168

Observed ORCID: 0000-0001-6559-7168

OpenAlex ID: A5033560715

TCR-engineered T cell therapy in solid tumors: State of the art and perspectives

2023 · Estelle Baulu, Célia Gardet, et al. · Science Advances · 483

Vangl2 Promotes Hematopoietic Stem Cell Expansion

2022 · Sarah Bouali, Roxann Hétu-Arbour, et al. · Frontiers in Cell and Developmental Biology · 2

Non-canonical translation of oncogenes in tumor cells generates a new class of shared and immunogenic neoepitopes for cancer immunotherapy

2026 · Stephane Depil, Estelle Baulu, et al. · Research Square

Développement et optimisation d'une thérapie cellulaire TCR-T ciblant les Rétrovirus Endogènes Humains (HERV)

2024 · Célia Gardet · theses.fr (ABES)

Targeting a shared neoepitope derived from non-canonical translation of c- MYC oncogene in cancer cells

2024 · E. Baulu, A. Bolon, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Works count: 5

Citation count: 485

H-index: 2

I10-index: 1